Archangel

Nathan D. Hamilton

Mr. Hamilton is a professional investor in life science
businesses, who brings with him over a decade of
biotechnology management experience to his portfolio. Mr.
Hamilton currently manages Archangel BioVentures, LLC
(ABV), a biomedical investment company, which he co-
founded with Bruce Ames PhD. In addition, Mr. Hamilton is
CEO of DynaTherm, and Director of Biolog, Inc. He is also an
entrepreneur, investor and consultant to several
biotechnology and medical device companies.

Prior to founding ABV, Mr. Hamilton served as President of
QIAGEN Operon where he built the business into the number
one synthetic DNA provider in the world.  During his time with
Operon, Mr. Hamilton and Robert Saul pioneered a new
technology for manufacturing high-quality DNA products. In
addition, Mr. Hamilton grew profitability and revenues at a
rate of over 100% in successive years, after which Mr.
Hamilton led the negotiation of Operon’s $150 million sale to
QIAGEN. QIAGEN Operon manufactures and sells a wide
range of nucleic acids, including full-length genes,
microarrays and oligonucleotides.

Mr. Hamilton received his B.A. in Physics from the University of
California, Berkeley and his Masters of Business Administration
from Harvard University Graduate School of Business.